MedPath

Efficacy of Guided Biofilm Therapy (GBT) for Treatment of Deep Periodontal Pockets.

Not Applicable
Not yet recruiting
Conditions
Periodontitis
Interventions
Procedure: guided biofilm therapy
Procedure: root surface debridement
Registration Number
NCT06319261
Lead Sponsor
University of Baghdad
Brief Summary

the aim of the study is to evaluate the efficacy of guided biofilm therapy (GBT) for treatment of deep periodontal pockets.

the objectives are

1- To compare the change in the clinical periodontal parameters and microbiological parameters by using real time PCR for P. gingivalis, Aggregatibacter actinomycetemcomitans and Filifactor alocis among sites treated by GBT and conventional hand instrumentation after a period of 3 months and to assess the level of the selected periodontal pathogens in deep periodontal pockets and to estimate and compare deep periodontal pockets which need surgery after 3 months of non-surgical treatment by GBT and conventional hand instrumentation.

the hypothesis is whether there are no differences in in the clinical and microbiological parameters among sites treated by GBT and conventional hand instrumentation after a period of 3 months or there are differences in in the clinical and microbiological parameters among sites treated by GBT and conventional hand instrumentation after a period of 3 months.

The participants will be selected on a consecutive basis from patients referred to the Department of Periodontics, College of Dentistry, University of Baghdad.

For each patient, each site will be randomly assigned to either treatment protocol:

1. Sites treated with GBT.

2. Sites treated with conventional manual instrumentation only.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
25
Inclusion Criteria
  1. Adult patients, aged more than 18 years.
  2. No history of any systemic diseases.
  3. Diagnosed with Stages 3 and 4 periodontitis according to the 2017 World Workshop on the Classification of Periodontal disease.
  4. The presence of deep periodontal pocket ≥ 6 mm in two non-adjacent teeth.
Exclusion Criteria
  1. Smokers.
  2. Pregnant and lactating mothers.
  3. History of any previous subgingival instrumentation in the last 3 months.
  4. The use of antibiotics/non-steroidal anti-inflammatory drugs in the last 3 months.
  5. Regular use of medication to control systemic illness.
  6. The presence of perio-endo lesion.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
guided biofilm therapy groupguided biofilm therapySites treated with guided biofilm therapy.
conventional root debridement grouproot surface debridementSites treated with conventional manual instrumentation only.
Primary Outcome Measures
NameTimeMethod
Periodontal pocket depth (PPD)3 months

PPD will be measured from the gingival margin to the base of the pocket by using the University of North Carolina 15 probe (UNC15) probe to measure the reduction of the pocket depth in millimeters.

Secondary Outcome Measures
NameTimeMethod
Relative attachment level3 months

Relative attachment level will be recorded by making a customized acrylic stent and then measuring the relative attachment level from a fixed point on the stent to the base of the pocket by using UNC15 probe in millimeters.

Bleeding on probing3 months

Bleeding on probing will be recorded as present (1) or absent (0) after probing all the sites by using UNC15 probe.

Changes in the bacterial load3 months

Real time polymerase chain reaction (qPCR) will be used to assess the detection and the quantity of these periodontal pathogens (P.gingivalis, Aggregatibacter actinomycetemcomitans and filifacter alocis) in the subgingival biofilm sample according to the manufacturer's instructions. identification of target bacteria through PCR will be executed using species specific primers.

Plaque index3 months

Biofilm will be determined using a dichotomous scoring system as present (1) or absent (0) after using a disclosing agent to assess the agreement on the scoring of the biofilm.

© Copyright 2025. All Rights Reserved by MedPath